Nuvectis Pharma, Inc.
USD9.46
+0.14 (+1.56%)
CEO
Ron Bentsur
IPO Date
2022-02-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.33
Prev. Close
$9.31
Day Low
$9.31
Day High
$9.46
52W Low
$5.55
52W High
$13.34
Market Cap
$0.25B
Volume
0.00M
| 150,000 |
| $0.00 |
| 9 Jan 2026 | Poradosu Enrique | Chief Science & Business Off | A-Award | Acquired | 150,000 | $0.00 |
| 9 Jan 2026 | Carson Michael J. | Vice President, Finance | A-Award | Acquired | 61,200 | $0.00 |
| 6 Nov 2025 | BENTSUR RON | director, 10 percent owner, officer: Chairman & CEO | P-Purchase | Acquired | 5,000 | $5.72 |
| 6 Nov 2025 | Sanchez Juan | director | P-Purchase | Acquired | 13,000 | $5.79 |
| 6 Nov 2025 | Kaplan Matthew L. | director | P-Purchase | Acquired | 11,000 | $5.84 |
| 31 Oct 2025 | Sanchez Juan | director | A-Award | Acquired | 30,000 | $0.00 |
| 31 Oct 2025 | Sanchez Juan | director | Disposed | 0 | $0.00 |
| 31 Oct 2025 | Sanchez Juan | director | Disposed | 0 | $0.00 |